Porras-Perales, Óscar
Segovia-Reyes, Jorge
Crespo-Delgado, Ángela
Ruiz-González, Diego
Flores-López, María
Medina-Vera, Dina
Sánchez-Marín, Laura
Martín-Chaves, Laura
Requena-Ocaña, Nerea
Molina-Ramos, Ana Isabel
Ruiz-Ruiz, Juan Jesús
Rodríguez de Fonseca, Fernando
Jiménez-Navarro, Manuel
Rodríguez-Capitán, Jorge
Pavón-Morón, Francisco Javier
Serrano, Antonia
Funding for this research was provided by:
Instituto de Salud Carlos III (FORT23/00013, PI22/01833, FORT23/00013, PI22/01833, RD21/0009/0003, PI22/01833, RD21/0009/0003, PI22/01833, PI22/01833, FORT23/00013)
Sociedad Española de Cardiología (SEC/FEC-INV-BAS23/18, SEC/FEC-INV-BAS23/18)
Plan Nacional sobre Drogas (PNSD 2022/020)
Article History
Received: 7 March 2025
Accepted: 18 June 2025
First Online: 1 July 2025
Change Date: 17 July 2025
Change Type: Update
Change Details: The original online version of this Article was revised: The Funding section in the original version of this Article was omitted. The Funding section now reads: “This research was supported by the following grants: Projects funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union and ERDF-EU (PI19/00886, PI20/01399, PI22/00427, and PI22/01833); Project funded by Delegación de Gobierno para el Plan Nacional sobre Drogas, Ministerio de Sanidad y Consumo (PNSD 2022/020); Project funded by Sociedad Española de Cardiología (SEC/FEC-INV-BAS23/18); Programa RICORS RIAPAD (RD21/0009/0003) funded by ISCIII and co-funded by the European Union; Programa Fortalece funded by ISCIII, Ministerio de Ciencia, Innovación y Universidades (FORT23/00013).” The original Article has been corrected.
Declarations
:
: The authors declare no competing interests.